Combating drug resistance in acute myeloid leukemia with a ceramide-based therapeutic
Researchers at the Medical University of South Carolina Hollings Cancer Center have discovered a mechanism that confers resistance to drugs used to treat certain types of acute myeloid leukemia (AML).
Targeting this pathway with a novel lipid- based therapeutic showed efficacy in a preclinical model of AML
View more at MUSC News
